December 5th 2023
Neurosteroid therapeutics could be the solution to provide fast-acting treatment for mothers with postpartum depression.
November 27th 2023
Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic
View More
Visualizing the Role of Antipsychotics in the Management of Schizophrenia: What is the Role of TAAR1?
View More
The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease
View More
Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis
View More
Advances In™ Schizophrenia: Expanding the Therapeutic Landscape
View More
Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia
View More
Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder
View More
5th Annual International Congress on the Future of Neurology®
View More
2023 Annual Psychiatric Times™ World CME Conference
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Intimate Partner Violence Victimization: How It Relates to Substance Use in Women
In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.
Read More
I Have a Dream, Too—A Social Psychiatric One
August 28th 2023As we commemorate the landmark March on Washington, parallels are drawn between Dr Martin Luther King Jr's dreams of equality and the goals of social psychiatry, highlighting the need to address social determinants of mental health.
Read More
The Rx Crisis: The Impact of Ongoing ADHD Medication Shortages
August 7th 2023According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD.
Read More